Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy H Ward

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|March 30, 2004
DiaziridinylbenzoquinonesAngela Maria Di Francesco, Timothy H Ward, John Butler
Anticancer Research|December 12, 2003
Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenograftsJeffrey Cummings, Alison Ritchie, John Butler, et al.
Anti-Cancer Drugs|July 20, 2005
Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancerIain A Bruce, Nicholas J Slevin, Jarrod J Homer, et al.
Biotechniques|October 29, 2003
Mycoplasma infection significantly alters microarray gene expression profilesCrispin J Miller, Heba S Kassem, Stuart D Pepper, et al.
The Journal of Gene Medicine|March 1, 2006
Radioprotective gene therapy through retroviral expression of manganese superoxide dismutaseThomas D Southgate, Victoria Sheard, Michael D Milsom, et al.
Biochemical Pharmacology|September 25, 2003
3-substituted-5-aziridinyl-1-methylindole-4,7-diones as NQO1-directed antitumour agents: mechanism of activation and cytotoxicity in vitroMohammed Jaffar, Roger M Phillips, Kaye J Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Preclinical evaluation of the pharmacodynamic properties of 2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinoneTimothy H Ward, Sarah Danson, Alan T McGown, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|March 30, 2004
DiaziridinylbenzoquinonesAngela Maria Di Francesco, Timothy H Ward, John Butler
Anticancer Research|December 12, 2003
Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenograftsJeffrey Cummings, Alison Ritchie, John Butler, et al.
Anti-Cancer Drugs|July 20, 2005
Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancerIain A Bruce, Nicholas J Slevin, Jarrod J Homer, et al.
Biotechniques|October 29, 2003
Mycoplasma infection significantly alters microarray gene expression profilesCrispin J Miller, Heba S Kassem, Stuart D Pepper, et al.
The Journal of Gene Medicine|March 1, 2006
Radioprotective gene therapy through retroviral expression of manganese superoxide dismutaseThomas D Southgate, Victoria Sheard, Michael D Milsom, et al.
Biochemical Pharmacology|September 25, 2003
3-substituted-5-aziridinyl-1-methylindole-4,7-diones as NQO1-directed antitumour agents: mechanism of activation and cytotoxicity in vitroMohammed Jaffar, Roger M Phillips, Kaye J Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Preclinical evaluation of the pharmacodynamic properties of 2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinoneTimothy H Ward, Sarah Danson, Alan T McGown, et al.
Pageof 1